Abstract: A short history of Alzheimer disease and vascular dementia is presented. The socio-medical events that led to the dominance of Alzheimer disease are discussed. Alzheimer's contributions to our current understanding of vascular dementia are reviewed.
In this regard, Kraepelin's classification of Dementia Praecox and Manic-Depressive disorders earned him considerable fame. 6 Moreover, the discovery that syphilis was associated with general paresis of the brain and was caused by the infection of the spirochete treponema pallidum was a seminal event in that a specific biologic substrate could now be associated with a specific neuropsychiatric illness. This event contributed to the beginning of what has come to be understood as biologic psychiatry. Thus, for Kraepelin and his associates, the degree that specific pathologic alterations could be associated with a specific set of clinical characteristics or symptoms became the methodology for the classification of disease states. It was this clinical-pathologic methodology that guided much of Alzheimer's work.
Concomitant with the development of this clinicalpathologic methodology, Alzheimer and Nissl contributed to the development of new histologic staining methods. Alzheimer and Nissl were friends, colleagues, and eventually worked with Kraepelin. 6, 7 Alzheimer was highly respected as a neuropathologist. Interestingly, he believed his most important work was not the 2 case studies that ultimately led to the designation of the disease that currently bears his name, but his 1904 thesis Histological Studies of the Differential Diagnosis of Progressive Paralysis. In this work he provided an integration of clinical and pathologic data as related to what was then considered a major neuropsychiatric illness (see Ref. 6, p. 2) .
It has been suggested that Alzheimer's over arching hypothesis was to show how certain catabolic products might provide evidence of biologic markers for neuropsychiatric conditions. 8 For Alzheimer these biologic markers in combination with clinical symptoms would ultimately lead to a diagnosis. Thus, the zeitgeist of the era suggested that medical scientists would ultimately be able to associate specific alterations in tissue with specific clinical symptoms and/or disease states. 5 It is within the context of what must have been such an incredibly stimulating and rich intellectual environment that Alzheimer concluded his 1907 description of Auguste: ''We must reach a stage in which the vast well-known disease groups must be subdivided into many smaller groups, each with its own clinical and anatomical characteristics.'' These ideas are prescient considering our current interest in possible physiologic overlap between AD and vascular dementia. 9 Much has been written regarding why or how it was that Kraepelin created the eponym Alzheimer's disease which first appears in the 1910 edition of his textbook. 6, 8, 10 By the year 1910, only 5 cases had been described in the literature, 2 of which were Alzheimer's patients. Nonetheless the combination of clinical characteristics, including the comparatively early (ie, presenile) onset and rapid course of dementia, the prominence of focal behavioral symptoms such as aphasia, agnosia, and apraxia, and neurofibrillary tangles, a comparatively new histologic alteration, seemed to be sufficient justification for Kraepelin to christen a new disease entity. Amaducci et al 10 stress the political nature of Kraepelin's actions (ie, his competition with Pick's neuropathologic laboratory in Prague). As has been pointed out by other researchers, 5 Kraepelin's scientific methods coupled with Alzheimer's interest in integrating histologic findings with a set of relatively unique clinical and pathologic characteristics seemed to justify the designation of a new disease state and confirm the merits of Kraepelin's clinical-pathologic methodology.
Still, during Alzheimer's lifetime there was no absolute consensus that Alzheimer's description of socalled presenile dementia actually constituted sufficient evidence for the labeling of a new disease state. In 1912, Solomon Carter Fuller, 11 a prominent psychiatrist and neuropathologist from Massachusetts, reviewed the existing literature on AD (15 cases; see Ref. 8 for a review). Not all cases presented with both senile plaques and neurofibrillary tangles; in some cases arteriosclerosis seems to be present, and in other cases other medical conditions were noted. It was also known during Alzheimer's life that neurofibrillary tangles and senile plaques were found not only in the brains of patients suffering from other neuropsychiatric conditions but also in the brains of individuals who, in life, did not seem to be demented. These facts have been recently rediscovered.
Alzheimer himself could be counted among the ''doubters'' who did not necessarily believe that AD represented anything but a precocious form of senile dementia. 8 It is interesting to note that Alzheimer's macroscopic description of Auguste's brain included evidence of vascular disease, that is, ''The larger cerebral vessels show arteriosclerotic changes'' (Alzheimer 3 22 was to show that ''arteriosclerotic degeneration can be distinguished easily from general paresis.'' Many of the clinical features we now commonly associate with multi-infarct dementia were discussed.
In 1898, Alzheimer reviewed a number of neuropsychiatric conditions of ''old age'' and offered a nosology of the vascular dementias. 23 Indeed, the recently proposed diagnostic criteria for vascular dementia [25] [26] [27] [28] have drawn upon the work of both Kraepelin and Alzheimer. In his 1898 paper, Alzheimer described 4 subtypes of vascular dementia. 23 For Alzheimer, the clinical characteristics of arteriosclerotic brain atrophy include ''a step-wise deterioration with shorter or longer intervals.'' Alzheimer also emphasized changes in personality, the emergence of depression, and the value of focal neurologic signs in the differential diagnosis. Alzheimer discusses a second form of vascular dementia, that is, Binswanger's encephalitis subcorticalis chronica progressiva and confirmed many of Binswanger's observations. [15] [16] Alzheimer goes on to offer a short discussion of 2 other forms of vascular dementia: perivascular gliosis or vascular dementia associated with embolic strokes and dementia apoplectica or vascular dementia due to hemorrhagic stroke. Alzheimer's 1902 paper entitled ''Mental Disturbances of Arteriosclerotic Origin'' has not received the attention it deserves. 24 Here, again, Alzheimer generously credits Binswanger's prior work. [15] [16] A most interesting aspect of this paper revolved around Alzheimer neuropsychologic description of dementia associated with subcortical white matter disease. Alzheimer's discussion of the neuropsychologic deficits associated with subcortical white matter disease clearly anticipated the now accepted differentiation between cortical and subcortical dementia. For example, Alzheimer described the memory impairment associated with subcortical white matter disease as a retrieval deficit, that is, ''difficulty in retrieving certain ideas, and not a true deficit.'' Alzheimer also associated ''prolonged reaction times'' (ie, bradyphrenia) with subcortical white matter dementia. It is unfortunate that Alzheimer's cogent clinical observations of vascular disease states coupled with his meticulous histologic examinations have been unappreciated. The dominance of AD within the family of the dementias can be traced to certain demographic and scientific events occurring in the late 1960s and 1970s. During this time, life expectancy was lengthening and there was an expectation that aging should be associated with a higher quality of life. The work of M. Powell Lawton and Elaine Brody, 31,32 Robert Kastenbaum, 33 Robert Katzman, 34 and many other researchers firmly established gerontology and geriatric medicine as important areas for scientific inquiry. Indeed, in 1975, the federal government invested in the developing interest in aging through the establishment of the Geriatric Research and Educational and Clinical Centers.
RISE AND DOMINANCE OF ALZHEIMER DISEASE
An important scientific development that led to the dominance of AD revolves around the Newcastle-UponTyne studies of Martin Roth and colleagues. The paper of Blessed et al 35 was seminal. This study combined the meticulous neuropathologic descriptions of the brains of dementia patients with neuropsychologic and behavioral data. The authors studied the brains of 60 patients. They found a strong association between the numbers of senile plaques found throughout the brain and performance on neuropsychologic and functional tests. For the first time a systemic analysis of behavior could be directly associated with pathology.
When viewed within a narrow context, the research of Blessed et al 35 tends to validate Kraepelin's clinicalpathologic methodology. The broader context of this study, however, was far-reaching, that is, the apparent linear relationship between pathology and behavior meant that an operational clinical-pathologic definition/ diagnosis of AD could now be made. Therefore, the dominance of AD, which dates from the middle 1970s, is the result of the realization that AD was not only quite prevalent (ie, ''a major killer,'' see Ref. 34 , p. 609), but that the illness could be subjected to systematic clinicalpathologic study.
ALZHEIMER'S ''OTHER DEMENTIA''
Throughout the 1980s and until the introduction of magnetic resonance imaging technology, vascular dementia was essentially abandoned and assigned inferior status. Within the family of the dementias, vascular dementia was definitely the problem child and like the late Rodney Dangerfield simply got no respect. The introduction of magnetic resonance imaging technology did much to rehabilitate and reclaim vascular dementia from the orphanage of neglected neurologic illnesses. Today, much of the controversy revolves around many of the same issues that were debated in Alzheimer's day. For example, some studies have shown that the incidence of so-called pure AD might be lower than previously believed. [36] [37] [38] Other research has suggested that vascular disease might modify the expression of the neuropathology associated with AD. [39] [40] [41] In transgenic animals, ischemic damage has been shown to facilitate the formation of b-amyloid plaques. 39 Finally, a prodromal state syndrome associated with vascular dementia termed ''VCI'' or vascular cognitive impairment has received much interest. [42] [43] [44] When we consider these contemporary data in conjunction with Alzheimer's own observations, perhaps it might be appropriate to view vascular dementia as Alzheimer's ''other dementia.''
